Publications

Andrews RM, Counahan ML, Hogg GG, McIntyre PB. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 2004;23:132-8. [Abstract]

Beutels P, Viney RC. Comments on the Prosser et al approach to value disease reduction in children [letter] . Pediatrics 2004;114:1375. [Abstract]

Lawrence GL, Boyd I, McIntyre P, Isaacs D. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Communicable Diseases Intelligence 2004;28:324-38. [Full text]

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 2004;22:3546-62. [Abstract]

Lawrence G, Boyd I. Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004. Communicable Diseases Intelligence 2004;28:490-2. [Full text]

Beutels P. Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination. Vaccine 2004;22:3312-22. [Abstract]

Lawrence GL, Burgess MA, Kass RB. Age-related risk of adverse events following yellow fever vaccination in Australia. Communicable Diseases Intelligence 2004;28:244-8. [Abstract]

Leask J, Williams A, McIntyre P, O'Dea D. Are General Practice Registrars prepared for immunisation? A cross sectional survey. Australian Family Physician 2004;33:665-7. [Abstract]

McIntyre P. Vaccines for other neonatal infections: vaccine strategies for prevention of neonatal pertussis. Expert Review of Vaccines 2004;3:375-8. [Abstract]

De Graeve D, Beutels P. Economic aspects of pneumococcal pneumonia: a review of the literature. Pharmacoeconomics 2004;22:719-40. [Abstract]